https://www.pharmaceutical-technology.com/pricing-and-market-access/germanys-fixed-pricing-for-medicines-faces-european-reckoning-html/ 2021-11-02T03:25:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gene-therapies/ 2019-11-04T16:31:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/next-gen-pneumococcal-vaccines-a-race-to-the-finish-or-a-foregone-conclusion/ 2023-05-22T03:42:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/highest-proportion-of-eye-cancer-cases-are-among-adults-ages-60-years-and-older-in-the-7mm/ 2022-10-14T13:07:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/breast-cancer-awareness-month-2019/ 2019-11-04T16:24:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/are-il-33-inhibitors-the-future-of-atopic-dermatitis-treatment/ 2023-03-16T07:25:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pancreatic-cancer-trials/ 2023-01-24T16:46:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cosentyx-huminra-psa-head-to-head/ 2019-11-01T11:45:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tmunity-funding-cancer-therapies/ 2019-11-01T09:42:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-beigene-stake/ 2019-11-01T10:52:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ema-satralizumab/ 2022-01-20T18:46:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dicerna-roche-heapatitis/ 2021-11-25T10:42:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/exscientia-ai-bispecific-small-molecule-drugs/ 2019-10-31T13:48:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brazil-p-vivax-tafenoquine/ 2019-10-31T11:15:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gdnf-future-parkinsons-treatment/ 2019-10-29T15:51:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-vumerity-relapsing-ms/ 2019-10-31T10:53:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pandion-astellas-diabetes/ 2020-02-12T11:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uegw-2019-stelara-boast-good-efficacy-and-safety-following-fda-approval/ 2019-11-04T15:46:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cancer-drugs-fund-nhs-reimbursement/ 2019-10-30T10:19:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-zolgensma-safety-issues/ 2022-03-24T11:20:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enesi-pharma-measles-rubella/ 2022-12-03T09:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-seroquel-rights/ 2019-10-30T11:12:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-ec-approval-dupixent/ 2023-05-30T04:28:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/dynamic-reform-in-international-reference-pricing-html/ 2021-11-02T03:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-the-dengue-dilemma/ 2023-06-15T04:16:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/wearable-digital-interventions-for-autism/ 2019-10-29T16:25:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/global-allergic-rhinitis-immunotherapy-market-set-to-reach-1-14bn-by-2028-driven-by-growth-in-the-us-and-japan-says-globaldata/ 2019-10-29T14:38:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/global-post-traumatic-stress-disorder-market-set-to-reach-us1-2-billion-by-2028-says-globaldata/ 2019-10-29T14:37:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/precision-medicine-set-to-make-steady-headway-in-japan-says-globaldata/ 2019-10-29T13:48:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/undiagnosed-cases-contribute-substantially-to-the-burden-of-allergic-rhinitis-says-globaldata/ 2019-10-29T13:39:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-glympse-nash-drug-development/ 2019-10-29T12:17:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/proteomics-in-clinical-trials/ 2023-01-24T16:47:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/carsgen-rmat-multiple-myeloma/ 2019-10-29T09:29:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-forest-namenda-lawsuit/ 2019-10-29T11:45:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ziopharm-md-anderson-alliance/ 2019-10-29T11:42:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gene-therapy-cmo-capacity/ 2022-03-24T10:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/prostate-cancer-incidence-is-increasing-in-younger-populations/ 2019-10-29T16:00:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pfizer-uk-counterfeit-drugs/ 2019-10-28T16:19:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-antibiotic-gonorrhoea/ 2019-10-28T13:35:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-mighty-patients-pharma-social-media/ 2023-01-24T16:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/medical-device-and-diagnostic-solutions-a-life-cycle-development-model-that-moves-your-device-ahead-of-the-game/ 2020-04-24T07:47:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zentiva-buys-alvogen-business/ 2019-10-28T11:10:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-ec-xospata-aml/ 2019-10-28T09:56:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/discovery-enables-flu-vaccines/ 2019-10-28T11:11:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/a1ad-most-common-in-those-of-european-descent/ 2023-06-05T05:26:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-low-price-repatha-supply/ 2019-10-25T10:28:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-botox-lower-limb-spasticity/ 2023-05-15T05:51:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-licenses-cystic-fibrosis-asset/ 2019-10-25T11:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/brexits-halloween-fright-night-for-pharmas-cmo-industry/ 2019-10-25T08:07:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/nhs-england-vertex-cf/ 2019-10-24T14:22:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-polio-day-eradicating-polio/ 2023-05-24T04:40:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/mulesoft-api-tools-drug-development/ 2019-10-24T07:50:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cardiovascular-trends-esc-twitter-q3-2019/ 2019-10-24T07:41:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-gates-foundation-research/ 2019-10-24T11:18:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-pliant-therapeutics-alliance/ 2019-10-24T08:27:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-tremfya-arthritis-approval/ 2019-10-24T09:01:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/takeda-entyvio-real-world-data-gi-diseases/ 2019-10-24T08:22:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-opdivo-yervoy-chemo-first-line-nsclc/ 2019-10-23T09:32:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pharmaceutical-packaging-increasing-productivity-and-reducing-carbon-emissions-with-aluminium-foil/ 2019-11-21T10:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-aducanumab-alzheimers/ 2019-10-23T10:16:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-licences-cour-drug/ 2019-10-23T08:42:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zealand-pharma-encycle-therapeutics/ 2021-11-22T08:57:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/sparingvision-innovation-eye-disease/ 2023-02-16T05:15:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-stelara-uc/ 2019-10-22T10:14:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cardiovascular-disease/ 2019-10-23T09:55:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vaccines-during-pregnancy-in-the-us/ 2019-10-23T09:54:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/opioid-litigation-settlement-ohio/ 2019-10-22T11:43:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-trikafta-fda-approval/ 2019-10-22T10:30:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/verseau-therapeutics-launch/ 2019-10-22T10:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-farxiga-cv-type-2-diabetes/ 2023-05-24T04:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/sharing-clinical-trial-data/ 2023-01-24T16:47:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-vaccines-bavarian-nordic/ 2021-11-22T06:41:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-roche-xofluza/ 2022-12-20T10:22:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-ebola-vaccine-chmp/ 2019-10-21T08:32:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approves-secuado-patch-for-schizophrenia/ 2021-12-02T05:26:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rare-diseases/ 2019-10-23T08:57:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-evenity-osteoporosis/ 2023-01-04T11:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-uk-recalls-ranitidine/ 2019-10-18T10:33:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adaptate-biotherapeutics-formation/ 2019-10-18T08:16:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/myasthenia-gravis-severity-is-more-grave-in-the-us/ 2022-11-24T12:09:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-ruxolitinib-graft-versus-host-disease/ 2021-09-10T12:03:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/swiss-success-story-pharma/ 2019-10-04T10:23:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/healx-series-b-funding/ 2019-12-23T10:53:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alexion-achillion-pharmaceuticals/ 2019-10-17T10:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trastuzumab-deruxtecan-priority-review/ 2019-10-17T11:27:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eli-lilly-set-to-lead-the-migraine-market-with-new-first-in-class-drug-approval/ 2022-03-17T03:58:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hpv-vaccination-to-boys/ 2019-10-16T14:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mundipharma-non-opioid-penthrox/ 2019-10-16T14:59:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unknowns-of-medication-in-pregnancy-conception/ 2019-10-04T10:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-astellas-pharma/ 2019-10-16T09:49:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-abbvie-acquisition/ 2019-10-16T08:17:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-blueprint-medicines/ 2019-10-16T09:17:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/queens-speech-nhs-life-sciences/ 2019-10-15T10:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ucb-takes-over-ra-pharma-to-expand-myasthenia-gravis-offering/ 2023-01-19T06:13:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cancer-cells-communicate-exosomes/ 2019-10-04T10:02:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-acino-nemea-deal/ 2019-10-15T12:01:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-digital-manufacturing-us/ 2019-10-15T09:00:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-xarelto-blood-clots/ 2019-10-15T11:19:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-jak1-atopic-dermatitis/ 2022-12-28T14:09:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/first-oral-glp-1-type-2-diabetes/ 2019-10-14T09:55:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/drug-resistant-tb/ 2019-10-04T09:23:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-fda-approval-reyvow/ 2019-10-14T10:31:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shionogi-hsiri-alliance/ 2022-09-01T13:23:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-approves-clovis-oncology-rucaparib/ 2019-10-14T13:07:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-acquires-ra-pharma-for-2-1bn/ 2021-11-25T10:05:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/risk-ocular-mg-generalized-mg-higher-smokers/ 2022-12-02T14:05:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringers-nintedanib-breakthrough-status/ 2019-10-11T11:21:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reata-bardoxolone-rights/ 2021-11-25T10:12:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alexion-stealth-elamipretide-deal/ 2019-10-11T10:59:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimers-disease-outlook/ 2019-10-23T07:13:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-bluebird-bio/ 2019-10-10T09:29:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clinuvel-fda-approval-scenesse/ 2021-11-22T09:59:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-acquires-ra-pharma/ 2019-10-10T09:21:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/amgen-enters-partnership-to-use-adaptive-biotechnologies-mrd-diagnostic-assay-for-haematology-drug-development/ 2019-10-22T15:06:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/taltz-humira-psoriatic-arthritis-joints-skin/ 2023-06-06T07:09:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/idweek-2019-influenza-treatment-options/ 2019-10-22T15:02:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icer-drug-price-hikes/ 2019-10-09T10:45:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-mobile-health-local-sample-collections-and-virtual-models-are-redefining-where-clinical-trials-happen/ 2020-04-24T07:47:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/future-of-cbd-drugs/ 2019-10-04T08:59:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-lyell-cell-therapies/ 2019-10-09T10:49:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-janssen-risperdal-lawsuit/ 2019-10-09T10:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-beovu-fda-amd/ 2019-10-09T13:13:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/infectious-disease-idweek-2019/ 2019-10-22T14:54:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-akcea-drug/ 2019-10-08T15:23:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/should-breast-cancer-screening-become-routine-in-high-risk-men/ 2019-10-22T14:49:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/are-we-entering-the-era-of-novel-inhaled-phosphodiesterase-inhibitors/ 2019-10-22T14:40:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/memory-loss-drugs-reverse/ 2019-10-04T08:47:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rituxan-gains-label-expansion-to-two-rare-forms-of-pediatric-vasculitis/ 2019-10-22T13:27:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-adolescent-mental-health/ 2019-10-07T14:09:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/medical-cannabis-in-the-uk-how-has-the-roll-out-gone-so-far/ 2019-10-04T08:27:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-hiv-tb-research/ 2019-10-07T10:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aggressive-breast-cancers-drug/ 2019-10-07T11:31:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-fasenra/ 2019-10-07T11:22:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/september-2019-top-news-stories/ 2019-10-07T14:16:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dengue-vaccine/ 2019-10-04T15:56:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/russia-serialisation-requirements/ 2019-10-04T11:09:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/goldfinch-takeda-monoclonal-antibody/ 2019-10-04T10:22:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emotional-challenges-art-hiv-viiv/ 2019-10-04T13:22:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cma-aspen-price-hike/ 2019-10-04T10:24:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-descovy-fda-hiv/ 2019-10-04T09:36:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-roche-tecentriq/ 2019-10-03T13:07:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2019-immuno-oncology/ 2022-11-03T05:14:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2019-bristol-myers-squibb/ 2019-10-03T12:39:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2019-roches-tecentriq/ 2019-10-03T12:13:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2019-biosimilars-in-oncology/ 2022-03-28T07:14:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/end-of-animal-testing-in-pharma/ 2019-10-02T11:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/keytruda-china-monotherapy-nsclc/ 2019-10-03T10:43:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/servier-acquires-pixuvri/ 2019-10-03T10:09:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-microsoft-ai-alliance/ 2022-11-23T12:09:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/keytruda-projections/ 2019-10-02T15:59:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/who-essential-medicines-list/ 2019-10-01T16:05:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-opioid-lawsuits-ohio/ 2019-10-02T10:58:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/ten-year-medicare-budget-impact-increased-coverage-anti-obesity-html/ 2021-11-02T03:25:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/respiratory-syncytial-virus-infections/ 2022-07-21T07:10:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eastern-equine-encephalitis-cases-point-to-rise-in-mosquito-borne-diseases-in-the-us/ 2019-10-01T12:25:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/boosting-african-dna-in-medical-research/ 2019-10-01T11:07:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-tecentriq-untreated-bladder-cancer/ 2019-10-01T10:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-dova-pharmaceuticals/ 2023-05-10T05:37:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cheplapharm-acquire-losecs-rights/ 2019-10-01T10:50:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moberg-pharma-deal-taisho/ 2019-10-01T13:00:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/south-korean-pharma-dreams-struggle-html/ 2021-11-02T03:25:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-merck-lynparza-results/ 2019-09-30T13:27:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kinoxis-opioid-withdrawal/ 2019-09-30T12:31:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-rituxan/ 2019-09-30T11:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/darzalex-multiple-myeloma/ 2019-09-30T11:37:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/polypill-major-cv-events/ 2019-09-27T10:41:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avanir-kickback-lawsuits-116m/ 2019-09-27T11:18:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/no-deal-brexit-medicines/ 2019-09-27T10:44:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-novartis-aimovig/ 2019-09-27T09:51:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-approval-mavyret/ 2019-09-27T09:40:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/achillion-pnh-drug-fda/ 2019-09-26T13:20:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/esmo-2019-digital-health-intervention-companies/ 2021-11-02T04:11:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/psoriasis-treatment-amgen-bms-celgene-otezla/ 2019-09-26T10:45:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/springworks-nirogacestat-europe/ 2021-11-23T08:17:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-us-manufacturing-investment/ 2019-09-26T09:59:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/car-t-cell-therapy-2/ 2019-09-26T10:27:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/economic-burden-elevated-blood-glucose-levels-in-2017-us-html/ 2021-11-02T03:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/smart-pill-bottle-non-adherence/ 2019-09-24T14:58:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-evotec-collaboration/ 2021-11-22T09:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gene-therapy-fanconi-rocket/ 2023-01-05T06:02:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/prostate-cancer-testing/ 2019-09-25T09:27:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-recommends-plegridy-avonex/ 2019-09-25T10:14:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-chronic-lung-diseases/ 2019-09-25T09:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-bavarian-nordic-jynneos/ 2019-09-25T10:53:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/treatment-outlook-for-patients-with-metastatic-castration-resistant-prostate-cancer-remains-poor/ 2023-01-24T16:48:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/world-alzheimers-day-future-of-care/ 2023-08-09T03:49:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/subscription-payment-for-medicines/ 2019-09-25T11:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-bayers-ntrk-vitrakvi/ 2019-09-24T12:35:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-recommends-astrazeneca-qtrilmet/ 2019-09-24T09:55:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/omega-therapeutics-epigenetic-drugs/ 2019-09-24T10:04:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/proteon-artara-therapeutics-merger/ 2019-09-24T11:43:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drc-second-vaccination-ebola/ 2019-09-23T13:34:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-investigating-zantac-for-carcinogenic-chemicals/ 2019-09-23T12:47:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/illegal-nortriptyline-data/ 2019-09-23T11:50:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-inflammasome-alliance/ 2019-09-23T11:33:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-semaglutide-rybelsus-diabetes/ 2019-09-23T08:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/deciphering-real-world-data-to-accelerate-clinical-trials/ 2020-04-24T07:47:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/diagnosed-ovarian-cancer-cases-set-to-reach-66000-across-seven-major-markets-in-2028-says-globaldata/ 2019-09-20T11:14:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/total-prevalent-cases-of-female-infertility-to-decline-to-13-4-million-in-2028-says-globaldata/ 2019-09-20T11:10:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/nursing-home-population-in-the-7mm-a-high-risk-group-for-rsv-infections-set-to-grow-by-24-to-6-2m-people-by-2028-says-globaldata/ 2019-09-20T11:06:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/alopecia-areata-market-set-to-be-worth-1-7bn-by-2028-driven-by-the-launch-of-jak-inhibitors-says-globaldata/ 2019-10-01T10:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/global-spinal-muscular-atrophy-market-set-to-reach-us6-6bn-in-2028-says-globaldata/ 2019-09-20T11:19:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/vaccines-for-alzheimers-similarities-with-down-syndrome/ 2019-09-21T08:50:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/global-hemophilia-a-and-b-market-set-to-reach-9-3bn-by-2028-says-globaldata/ 2019-09-20T10:24:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trintellix-depression-japan-takeda-lundbeck/ 2019-09-20T14:18:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/infectious-disease-trends-ebola/ 2019-09-20T07:45:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanbio-cell-therapy-fda/ 2019-09-20T08:10:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-nice-recommends-takhzyro/ 2019-09-20T07:57:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drug-combo-lung-cancer/ 2019-09-20T07:47:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/diabetes-metabolic-disorder-twitter-trends/ 2019-09-20T07:44:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/using-viruses-to-fight-disease/ 2022-03-23T10:39:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-zolgensma-data-children-sma/ 2019-09-19T14:24:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizers-upjohn-and-mylan-merger-set-to-create-drug-and-manufacturing-juggernaut/ 2019-09-23T11:23:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/andhra-pradesh-and-telangana-indian-contract-manufacturing-powerhouses-for-us-api-supply/ 2019-09-19T11:19:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/versantis-series-b-funding/ 2019-09-19T09:12:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-ironwood-linzess-deal/ 2019-09-19T09:04:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-gazyva-fda-breakthrough/ 2019-09-19T08:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/challenges-nhs-cancer-treatment/ 2019-09-18T14:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/keytruda-combination-endometrial-carcinoma/ 2023-01-11T18:54:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/can-sleep-disruptions-lead-to-alzheimers-disease/ 2019-09-18T10:56:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/world-alzheimers-day-letstalkaboutdementia/ 2021-12-03T10:07:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-therapies-review/ 2019-09-18T09:51:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-methotrexate-blood-cancer/ 2022-07-21T11:33:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncoheroes-boehringer-licence-deal/ 2022-12-20T10:21:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-v920-ebola-vaccine/ 2019-09-17T14:49:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vaping-lung-disease/ 2019-09-17T10:22:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-track-farxiga/ 2019-09-17T09:30:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lundbeck-alder-biopharmaceuticals/ 2019-09-17T09:22:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amplyx-novartis-bkv-candidate/ 2019-09-17T10:47:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-eisai-discontinue-alzheimers-trials/ 2023-01-24T16:49:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/unmet-needs-remain-in-rheumatoid-arthritis-for-patient-satisfaction-and-symptom-management/ 2022-11-29T15:39:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cancer-therapy-washington-post-live-event-entitled-chasing-cancer/ 2019-09-16T09:51:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ranitidine-review/ 2019-09-16T10:09:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aytu-bioscience-innovus-pharma/ 2019-09-16T10:49:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purdue-pharma-bankruptcy/ 2019-09-16T10:50:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/resolving-drug-resistance-in-lymphoma/ 2019-09-16T08:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-ocrevus-disease-progression-ms/ 2019-09-13T10:52:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-nucala-fda-children/ 2019-09-13T09:13:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inotrem-series-b-funding/ 2019-09-13T11:28:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-therapy-heart-disease/ 2019-09-13T08:57:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-cf-drug-orkambi-available-scotland/ 2019-09-12T16:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/disruption-to-medicines-no-deal-brexit-operation-yellowhammer/ 2019-09-12T10:08:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-drug-children/ 2019-09-12T10:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atomwise-ai-drug-deals/ 2019-12-23T10:53:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-initiates-genome-project/ 2019-09-12T10:25:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gene-therapy-genenta-funding-round/ 2019-09-11T10:47:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-drug-manufacturing-unit/ 2019-09-11T10:42:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-buys-sitari-pharmaceuticals/ 2019-09-11T10:22:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lexicon-sanofi-zynquista-settlement/ 2019-09-11T08:52:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/draper-car-t-therapy-manufacturing/ 2019-09-10T18:18:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssens-esketamine-reduces-symptoms-in-suicidal-depression/ 2019-09-10T11:35:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ofev-fda-approval/ 2022-08-16T10:22:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/flexion-xenon-pain-therapy/ 2019-09-10T10:05:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmab-tempus-partnership/ 2021-12-02T07:48:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-imfinzi-untreated-sclc/ 2019-09-09T14:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-tecentriq-cancer-ec/ 2019-09-09T11:57:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-insulin-discount/ 2019-09-09T10:24:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esc-updates-first-line-treatment-guidelines-for-type-2-diabetics-with-cardiovascular-disease/ 2019-09-06T15:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-stelara-ulcerative-colitis/ 2019-09-06T11:02:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ifm-due-novartis-agreement/ 2023-01-10T08:52:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sumitomo-dainippon-roivant/ 2021-10-27T12:41:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nkarta-therapeutics-series-b/ 2019-09-06T08:54:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/type-2-diabetes/ 2023-01-23T13:39:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/theragnostics-radiopharmaceuticals-parpi/ 2019-09-05T11:06:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/august-2019-top-news-stories-pharma/ 2019-09-12T15:49:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-biomotiv-alliance/ 2019-09-05T11:00:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-lupin-agreement/ 2019-09-05T11:49:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-receives-nod-tagrisso-china/ 2019-09-05T10:59:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/vertex-semma-acquisition-diabetes 2019-09-04T12:44:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/farxiga-efficacy-in-heart-failure/ 2019-09-04T11:33:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-novartis-luxturna/ 2019-09-04T11:54:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-acquires-semma-therapeutics/ 2022-03-24T10:22:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cidara-mundipharma-rezafungin-deal/ 2019-09-04T10:58:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/achilles-personalised-cell-therapies-100m-round/ 2019-09-03T10:48:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-cmo-cdmo-facilities-can-gain-value-with-single-use-containment/ 2020-02-17T14:50:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inotrem-nangibotide-fda/ 2022-07-21T10:35:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insilico-ai-drug-discovery/ 2019-12-23T10:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-polpharma-natalizumab-biosimilar/ 2019-09-03T10:37:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/heart-failure-drug-entresto/ 2019-09-02T11:24:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/takeda-shire-deal-japan-largest-foreign-acquisition 2019-09-02T10:06:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gavi-fundraising-immunisation/ 2019-09-02T08:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/malaria-drug-prevents-spread/ 2019-09-02T07:59:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-hrt-for-menopause-increases-breast-cancer-risk/ 2022-12-02T15:19:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/springworks-breakthrough-status-desmoid-tumour-drug/ 2019-08-30T10:07:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adcendo-loan-advance-adcs/ 2019-08-30T10:26:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-sle-drug/ 2019-08-29T13:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/oklahoma-wins-landmark-suit-against-jj-for-role-in-opioid-crisis/ 2019-09-02T14:53:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-sees-increase-in-severe-pulmonary-disease-likely-linked-to-e-cigarettes/ 2019-08-30T08:24:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/resurrection-of-fedratinib-results-in-fda-approval-for-myelofibrosis/ 2019-08-29T10:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/the-current-clinical-trial-space-for-tuberculosis/ 2019-08-29T10:05:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/glenmark-wins-regulatory-approval-to-market-diabetes-drug-in-india/ 2021-12-02T06:16:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/az-versus-gsk-the-battle-in-front-line-treatment-of-ovarian-cancer/ 2019-08-29T08:59:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/beyond-cosmetics-repurposing-drugs-against-aging/ 2019-08-29T09:12:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-nourianz-parkinsons/ 2019-08-29T10:09:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lannett-posaconazole-us/ 2019-08-29T10:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-ec-approval/ 2019-08-29T11:15:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/abbvie-scores-fda-approval-for-ra-therapy-amid-safety-concerns/ 2019-08-30T08:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approves-xenleta-for-community-acquired-bacterial-pneumonia/ 2019-08-28T15:53:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-apis-pharmaoffer/ 2019-08-28T13:33:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/tb-alliances-pretomanid-receives-fda-approval-for-tuberculosis/ 2019-08-28T13:16:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/top-drugs-used-in-huntington-disease-clinical-trials/ 2023-05-09T05:23:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purdue-pharma-settles-opioid-lawsuits/ 2019-08-28T09:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zogenix-modis-therapeutics-deal/ 2021-11-25T09:34:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ckd-farxiga-fast-track/ 2022-11-29T15:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/empliciti-multiple-myeloma/ 2019-08-29T05:53:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hiv-mortality-in-china-is-increasing-faster-for-men-than-women/ 2019-08-27T16:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/innovative-sma-treatments-genetics/ 2021-11-25T09:56:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/a-new-chlamydia-vaccine-on-the-horizon/ 2023-02-03T10:52:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/are-mas-the-key-to-securing-growth-in-the-orphan-drugs-sector/ 2019-08-27T11:52:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ovarian-cancer-diagnoses-increase-across-6-of-the-7-major-markets/ 2023-02-03T10:45:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/melas-in-the-16-major-markets/ 2019-08-27T11:34:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-male-breast-cancer-recommendations/ 2019-08-27T09:51:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-liability-opioid-case/ 2019-08-27T12:42:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-wall-immunotherapy/ 2019-08-27T09:36:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-otezla-celgene/ 2019-08-27T09:49:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-refractory-multiple-myeloma-drug/ 2019-08-23T13:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/lynparza-in-2019/ 2019-08-23T11:53:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/patient-compliance-is-found-wanting-for-those-with-alopecia-areata/ 2023-01-24T16:49:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-deals-in-july-2019 2019-08-23T09:24:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinook-therapeutics-seriesa-round/ 2019-08-23T10:42:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-eradicating-malaria/ 2019-08-23T13:46:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-daprodustat-japan-submission/ 2019-08-23T09:49:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/janssen-and-abbvie-imbruvica-2019/ 2019-08-22T14:44:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/medidata-past-future-rd/ 2019-08-29T14:22:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-buyers-clubs-in-the-uk/ 2019-08-22T10:11:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/amarin-vascepa-2019/ 2019-08-22T10:00:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/do-mental-health-drugs-work/ 2019-08-19T08:36:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-fund-haemophilia-a-hemlibra-2/ 2019-08-22T10:48:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-gene-therapy-facility/ 2019-08-22T09:55:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-crick-research-alliance/ 2019-08-22T10:29:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-deals-in-july-2019 2019-08-21T13:44:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cf-buyers-club-uk-access-orkambi/ 2019-08-21T09:27:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/imfinzi-stage-vi-nsclc-failure/ 2019-08-21T11:08:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-golodirsen-fda-crl/ 2023-06-26T05:42:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-animal-health-deal/ 2019-08-21T11:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/northern-antibiotics-new-molecule/ 2019-08-21T09:44:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/partnerships-are-shaping-late-stage-pipeline-of-ovarian-cancer-treatment/ 2019-08-20T14:09:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/real-world-data-improving-outcomes/ 2019-08-14T08:45:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-farxiga-heart-failure/ 2019-08-20T09:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaxxilon-vaccine-development-grant/ 2023-06-12T04:09:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mateon-pointr-ai-oncology/ 2019-12-23T10:56:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nabriva-xenleta-fda-approval/ 2019-08-20T09:10:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/as-court-bans-compounding-of-endo-hormone-data-shows-injectables-are-the-largest-service-at-503b-outsourcing-facilities/ 2023-01-24T16:50:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/tackling-ebola-drugs-alone-cannot-end-the-outbreak/ 2019-08-19T15:45:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/injury-heart-attack-recovery/ 2019-08-19T13:32:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-patient-centricity-is-enabling-the-reality-of-virtual-trials-and-mhealth/ 2020-04-24T07:47:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-inrebic-fda-approval/ 2019-08-19T09:46:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/juvenescence-series-b-closing/ 2019-12-23T10:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wakix-first-narcolepsy-drug/ 2019-08-19T12:28:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-rozlytrek-fda-approval/ 2019-08-16T09:01:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-medicines-freight-service/ 2019-08-16T09:59:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lynparza-ovarian-cancer-results/ 2019-08-15T13:54:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-taltz-outperforms-tremfya-psoriasis/ 2019-08-14T13:54:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/generic-drugs-industry-2019/ 2019-08-14T13:34:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/teruko-ishizaka-allergic-reactions-antibodies/ 2023-06-20T04:52:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/curevac-yale-lung-therapies/ 2019-08-14T11:14:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-calquence-cll/ 2019-08-14T13:23:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-virtual-center/ 2019-08-14T11:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/deals-interview-healthcare 2019-08-13T13:04:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/roches-imvigor-130-study-reads-a-positive-result-for-co-primary-endpoint-in-bladder-cancer/ 2019-08-13T11:53:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/progress-first-chlamydia-vaccine/ 2022-12-02T12:30:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/genetics-for-psoriasis-drug-development/ 2019-08-13T08:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jazz-pharmaceuticals-buys-cavion/ 2019-08-13T09:40:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-senator-novartis-zolgensma/ 2019-08-13T10:01:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sonnet-buys-relief-therapeutics/ 2019-08-13T11:51:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/river-blindness-prophylactic-vaccines/ 2023-02-06T07:09:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/non-hodgkins-lymphoma-roche/ 2019-08-12T13:39:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/unprecedented-global-demand-for-gardasil/ 2019-08-12T11:51:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/high-mortality-breast-cancer-aspirin/ 2019-08-12T10:45:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-court-amgen-enbrel/ 2019-08-12T09:49:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-gileads-hiv-1/ 2019-08-12T10:58:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canada-medicines-prices-reforms/ 2019-08-12T11:08:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/taking-the-pulse-of-international-reference-pricing-html/ 2021-11-02T03:25:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-tagrisso-ecfr-tkis/ 2023-06-07T04:43:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gamamabs-cancer-has-trial-planned/ 2023-01-24T16:50:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/genfits-elafibranor-trial-to-close-enrolment/ 2019-08-09T10:10:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimer-blood-test-clinical-use/ 2019-08-09T12:55:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/therapy-genetic-obesities-excels-in-trial/ 2019-08-09T09:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oric-funding-oric-101/ 2019-08-09T09:49:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dynacure-orphan-drug-designation/ 2019-08-09T08:40:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apratoxin-s4-vision-loss/ 2019-08-09T13:05:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/allakos-positive-results/ 2021-11-23T08:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-approves-keytruda-nhs-nsclc/ 2019-08-08T13:56:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/positive-result-roche-imvigor-study/ 2019-08-08T10:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-nda-vedolizumab/ 2019-08-08T10:49:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-bluerock-therapeutics/ 2019-08-08T13:48:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hummingbird-cancer-research/ 2019-08-08T07:33:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/automated-blood-plasma-warehouse/ 2019-08-08T13:05:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eu-approval-nucala/ 2019-08-07T13:42:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-personalised-breast-cancer-treatment/ 2019-08-07T11:42:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-novartis-zolgensma-data-concerns/ 2019-08-07T10:20:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-ebola-marburg-vaccines/ 2019-08-07T11:32:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/permira-acquire-cambrex/ 2019-08-07T11:51:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-orphan-drug-designation/ 2019-08-07T08:33:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atopic-dermatitis-dupixent-sanofi/ 2023-01-23T13:36:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novartis-misses-endpoint/ 2019-08-06T11:07:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/keytruda-and-inlyta-combination-approval/ 2019-08-06T10:38:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/abbvie-insurance-scrutiny/ 2019-08-08T15:13:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/roches-therapy-faces-struggle-against-spinraza/ 2019-08-08T15:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/breakthroughs-in-hiv-treatment-timeline/ 2019-08-06T07:53:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/innovative-technologies-tableting/ 2019-11-14T05:41:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-shenogen-tyvyt-cancer/ 2019-08-06T10:23:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sosei-group-takeda-drug/ 2019-08-06T10:49:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/foamix-fmx103-rosacea/ 2022-12-07T14:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/july-top-news-stories-pharma/ 2019-08-09T14:17:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/geographical-trends-in-immunotherapy/ 2023-06-20T04:53:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/restless-leg-syndrome-diagnosis/ 2019-08-05T14:05:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/otezla-fda-approval/ 2019-08-05T13:12:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/verona-copd-drug-positive-results/ 2019-08-05T13:03:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/misdiagnosis-hidradenitis-suppurativa/ 2019-08-05T10:53:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-turalio-tgct/ 2019-08-05T09:54:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santhera-chiesi-raxone-licensing/ 2019-08-05T11:14:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antikor-essex-investment-cancer/ 2019-08-05T14:10:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sensyne-health-bayer-alliance/ 2019-12-23T10:53:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bempegaldesleukin-opdivo-melanoma/ 2019-08-02T10:27:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acg-engineering-buys-xertecs/ 2019-08-02T09:51:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/irish-green-credentials-fail-on-pharmaceutical-waste-exports-html/ 2021-11-02T03:25:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/precision-oncology-treatment-2019/ 2019-08-01T15:38:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hypoglycemia-treatment-2019/ 2023-05-08T05:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hepatitis-b-cure-2019/ 2021-12-02T05:17:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ebola-prevention-issues-2019/ 2019-08-01T11:22:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-price-fixing-teva/ 2020-01-31T13:54:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-consumer-healthcare-jv/ 2019-08-01T09:54:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/exelixis-aurigene-licensing-deal/ 2021-12-02T09:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hhs-fda-drugs-import-plan/ 2019-08-01T11:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bio-2019-regulatory-designations/ 2019-07-31T15:18:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/type-1-diabetes-and-sglt-2019/ 2022-08-16T10:56:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/lymphoma-treatment-2019/ 2021-11-25T10:15:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/triple-negative-breast-cancer-treatment-2019/ 2022-01-20T20:43:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/spinal-muscular-atrophy-treatment-2019/ 2019-07-31T10:23:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/dangers-of-unlicensed-stem-cell-clinics/ 2019-07-30T13:14:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pay-as-you-go-ai-drug/ 2019-07-31T13:16:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alligator-bioscience-regains-asset/ 2019-07-31T10:59:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-pay-for-delay-settlement/ 2019-07-31T09:52:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/darolutamide-fda-approval/ 2019-07-31T10:27:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/breast-milk-and-oncology-2019/ 2022-01-20T20:33:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/taming-the-pharma-monster-hedley-rees/ 2019-07-22T10:09:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/lung-cancer-treatment-2019/ 2021-11-23T12:03:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/potentially-revolutionary-treatment-for-copd-verona-ensifentrine/ 2020-01-10T14:33:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-pfizer-upjohn-deal/ 2019-07-30T11:07:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viiv-janssen-cabotegravir-rilpivirine/ 2019-07-30T13:07:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lyndra-therapeutics-oral-contraceptive/ 2019-07-30T11:20:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/world-lung-cancer-day-2019/ 2019-07-29T16:31:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-taming-big-pharma/ 2019-07-29T15:14:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-approves-13-medicines/ 2022-01-20T18:45:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rethinking-payments-for-hepatitis-c-drugs/ 2019-07-29T08:35:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-nhs-astrazeneca-olaparib/ 2019-07-29T11:06:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-xeljanz-boxed-warning-fda/ 2019-07-29T13:48:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wellcome-genomics-in-cancer-database/ 2019-07-26T11:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/colorectal-cancer-stivarga-quality-of-life/ 2019-07-26T13:08:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-hepatitis-day-developing-more-effective-hepatitis-b-drugs/ 2020-01-24T11:01:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zambon-buys-breath-therapeutics/ 2019-07-26T14:21:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-baqsimi-hypoglycaemia-fda-nod/ 2019-07-26T11:16:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-verastem-copiktra-licensing/ 2019-07-26T11:12:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/switzerland-joins-major-players-to-house-high-containment-api-manufacturing-facilities/ 2019-07-25T14:35:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/lyme-disease-treatment-2019/ 2019-07-26T14:42:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-myeloma-treatment-xpovio-2019/ 2019-07-25T11:15:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-opdivo-primary-endpoint-nsclc/ 2019-07-25T10:18:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gemphire-neurobo-pharmaceuticals-merge/ 2021-11-22T09:36:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-bioepis-hadlima-fda-nod/ 2019-07-25T11:26:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-chikungunya-vaccine-grant/ 2019-07-25T11:17:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/adequate-funding-and-education-is-key-to-eliminating-malaria/ 2019-07-24T16:57:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/asco-2019-prostate-cancer-updates/ 2019-07-24T13:12:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/an-overview-of-leukaemia-trials-role-of-biomarkers-in-success/ 2023-01-24T16:50:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/myovant-uterine-fibroid-results/ 2022-12-20T10:38:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/conjunctivitis-treatment-2019/ 2019-07-24T11:00:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-jounce-licensing-deal/ 2019-07-24T10:04:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-bipartisan-bill-lower-drug-prices/ 2019-07-24T12:34:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-research-consortium-tb-drugs/ 2019-07-24T11:25:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-merck-lenvima-keytruda-breakthrough/ 2019-07-24T10:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bladder-cancer-treatment-2/ 2019-07-23T14:24:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-triple-combination-cf-drug/ 2019-07-23T09:31:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-lyrica-generics/ 2021-11-22T08:06:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-otc-rights-tamiflu/ 2019-07-24T09:30:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/venatorx-new-antibiotic-alliance/ 2019-07-24T08:11:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/zolgensma-cost/ 2019-07-22T12:03:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sumitomo-dainippon-schizophrenia-drug/ 2021-10-27T12:40:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biohaven-nurtec-fails-fda-approval/ 2023-01-30T15:56:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-novartis-antiviral-programmes-deal/ 2019-07-22T11:36:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-europe-submission-sc-darzalex/ 2019-07-22T11:55:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/oncology-kras-inhibitors-2019/ 2021-11-25T09:37:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/postpartum-depression-treatment-2019/ 2019-07-19T12:52:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-bridge-biotherapeutics-alliance/ 2019-07-19T12:14:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-nice-backs-novartis-kisqali/ 2019-07-19T11:29:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-silence-therapeutics-deal/ 2019-07-19T14:10:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/forxiga-interest-widens-2019/ 2023-05-12T05:14:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/innovative-treatments-sarcoma-forgotten-cancer/ 2023-01-11T17:15:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trojan-horse-chemo-drug-delivery-system/ 2019-07-19T05:41:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-recarbrio-fda-nod/ 2019-07-18T13:35:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-frequency-therapeutics-licensing/ 2019-07-18T09:46:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aum-biosciences-inflection-licence-deal/ 2019-07-18T10:46:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/lupus-childbirth-study/ 2019-07-17T10:48:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dlbcl-incidence-study-us/ 2019-07-17T10:02:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gotham-mercachem-epitranscriptomic-library/ 2019-07-17T09:33:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genomic-barcode-tracks-immune-cells/ 2019-07-17T13:47:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sosei-heptares-genentech-alliance/ 2019-07-17T10:52:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kite-new-manufacturing-facility/ 2019-07-17T11:17:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/china-pharma-industry-deals-in-q2-2019 2019-07-16T13:42:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/north-america-pharma-industry-deals-in-q2-2019 2019-07-16T13:37:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/europe-pharma-industry-deals-in-q2-2019 2019-07-16T13:31:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/hpapi-dealing-with-containment-challenges/ 2019-11-21T10:18:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-q2-2019 2019-07-16T13:16:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/venture-capital/us-pharma-industry-venture-financing-deals-in-q2-2019 2019-07-16T13:10:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-deals-in-q2-2019 2019-07-16T13:07:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/private-equity/pharma-industry-private-equity-deals-in-q2-2019 2019-07-16T13:02:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/venture-capital/pharma-industry-venture-financing-deals-in-q2-2019 2019-08-22T04:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cancer-immunotherapy-2019/ 2019-07-16T12:57:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-ma-deals-in-q2-2019 2019-07-16T12:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dry-eye-syndrome-2019/ 2023-03-03T11:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/haemophilia-epidemiology-forecast/ 2019-07-16T11:20:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/am-pharma-sa-aki-trial/ 2022-07-21T10:36:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-opioid-crisis-insys/ 2019-07-23T15:09:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-deals-in-june-2019 2019-07-16T06:28:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-deals-in-june-2019 2019-07-16T04:32:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-june-2019 2019-07-16T04:14:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-acquires-amal-therapeutics/ 2019-07-16T14:15:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oklahoma-jj-opioid-trial/ 2019-07-16T13:38:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recursion-raises-121m-ai-drug-discovery/ 2019-12-23T10:53:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/venture-capital/pharma-industry-venture-financing-deals-in-june-2019 2019-07-15T16:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-oncology-acquisition-mavupharma/ 2019-07-15T15:36:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alopecia-areata-treatment-2019/ 2023-05-25T05:31:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/europe-pharma-industry-deals-in-june-2019 2019-07-15T13:04:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gilead-galapagos-rd-deal/ 2021-12-02T09:49:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-imfinzi-orphan-status-us/ 2019-07-15T09:42:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-galapagos-deepen-alliance/ 2019-07-15T14:16:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recordati-signifor-osilodrostat-novartis/ 2021-12-02T12:16:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimers-disease-treatment-2019/ 2019-07-12T14:36:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/myorelaxant-cannabis-cream-2019/ 2019-07-12T13:11:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizers-lorbrena-in-ros1-non-small-cell-lung-cancer-xalkori-treated-patients-to-be-presented-at-wclc/ 2023-01-24T16:51:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esophageal-cancer-treatment-2019/ 2019-07-15T08:45:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-novartis-discontinue-alzheimers-drug-development/ 2019-07-12T10:46:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/epipen-spinal-cord-injuries/ 2019-07-12T14:06:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-dementia-research-facility-us/ 2019-07-12T09:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/life-sciences-supply-chain-brexit/ 2020-09-21T14:12:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reckitt-resolves-indivior-opioid-probe/ 2019-07-12T17:24:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/global-pompe-disease-2019/ 2023-07-31T07:09:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vasopharm-financing-round/ 2019-07-11T15:20:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pnh-treatment-2019/ 2019-07-11T10:12:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-sanofi-isatuximab-bla/ 2019-07-11T11:30:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-epinephrine-injection-us/ 2019-07-11T11:43:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approves-gsk-pfizer-jv/ 2019-07-11T13:44:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/car-t-therapy-reimbursement-us/ 2019-07-10T16:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-just-in-time-hydration-is-optimised-by-single-use-powder-handling/ 2019-11-21T10:18:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-lyndra-hiv-drugs/ 2019-07-10T09:57:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/its-quite-unique-how-mixed-reality-is-transforming-remote-services/ 2019-11-21T10:15:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/aera-ai-in-pharma-supply-chains/ 2023-01-24T16:51:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-antibiotics-payment-model/ 2019-07-10T11:48:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-325m-funding/ 2019-07-10T09:49:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jazz-buys-redx-oncology-asset/ 2019-07-10T13:52:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/addex-nam-ptsd-consortium/ 2019-07-09T11:22:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/haemophilia-treatments-2019/ 2019-07-15T13:34:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-spin-off-breakpoint-therapeutics/ 2021-11-22T09:54:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-judge-blocks-hhs-drug-prices-rule/ 2019-07-09T12:36:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-and-skyhawk-therapeutics-sign-collaboration-agreement/ 2019-07-09T09:51:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/epileptogenesis-research-2019/ 2019-07-08T11:02:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-bull-market-2019/ 2019-07-08T09:55:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-utah-uni-potential-diabetes-target/ 2023-01-05T06:18:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-pfizer-dacomitinib/ 2019-07-08T11:41:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-forms-protacs-research-collaboration/ 2019-07-08T12:28:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/neuroparalytic-disorders-2019/ 2023-05-24T04:42:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gene-therapy-2019/ 2019-07-05T20:18:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/immune-system-2019/ 2023-05-02T09:59:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-grifols-xembify-for-immunodeficiencies/ 2019-07-05T13:32:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/common-cold-virus-kills-bladder-cancer/ 2019-07-05T13:34:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nosopharm-evotec-antibiotics-alliance/ 2021-11-22T10:11:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-spinraza-access-agreement/ 2019-07-05T10:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/biotechnology-in-the-uk/ 2019-07-24T12:36:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/binding-of-drug-to-mitochondria-model/ 2019-07-04T13:57:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-karyopharm-xpovio/ 2021-11-23T11:33:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dundee-bukwang-pharmaceutical-deal/ 2019-07-04T09:47:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crispr-study-potential-hiv-cure/ 2019-07-04T12:55:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/libtayo-approved-for-cscc-in-the-eu-including-through-the-nhs-in-the-uk/ 2019-07-03T10:01:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-opinion-astrazeneca-fasenra-pen/ 2019-07-03T10:06:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/century-therapeutics-launch-financing/ 2019-07-03T10:47:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-takeda-xiidra-deal/ 2019-07-10T10:28:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viiv-healthcare-receives-ma-in-europe-for-dovato/ 2019-07-03T12:38:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cannabidiol-uses-2019/ 2019-07-02T15:39:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/diabetes-trends-in-the-us/ 2019-07-02T15:14:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/c-difficile-treatment-2/ 2022-11-28T15:56:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/glp-1ra-receptor/ 2019-07-02T14:12:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/crohns-disease-benchmarking-2019/ 2019-07-02T13:45:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/top-oncology-influencers/ 2021-10-31T15:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-acquires-therachon-340m/ 2019-07-02T11:27:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taisho-pharma-bms-upsa-acquisition/ 2019-07-02T10:42:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-sv-health/ 2019-07-02T14:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-yuhan-alliance/ 2021-12-02T05:20:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/popular-gene-therapies-2019/ 2019-07-01T16:12:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-china-pharma-trade-2019/ 2019-07-01T15:25:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biologics-investment-2019/ 2019-07-01T15:35:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/nationalised-drug-company-future-of-pharma/ 2020-01-24T11:00:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-zirabev-fda-approval/ 2019-07-01T10:43:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-chmp-imbruvica-indications/ 2023-01-17T10:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sensorion-ema-sens-401-indications/ 2019-07-01T09:50:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/antimicrobial-resistance-2019/ 2019-06-28T14:46:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-soliris-nmosd-alexion/ 2022-02-18T12:30:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mantle-cell-lymphoma-therapies/ 2019-06-28T14:14:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/world-hepatitis-day-2019/ 2019-06-28T13:38:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biopharma-clusters-2019/ 2019-06-28T12:48:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vivus-nordmark-pancreaze-capsules/ 2019-06-28T12:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sun-pharma-cms-csa-eye-drops/ 2019-06-28T10:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/springworks-gsk-nirogacestat-belantamab/ 2023-01-05T06:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hypoactive-sexual-desire-disorder-treatment-2019/ 2022-11-30T14:32:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/type-1-diabetes-triggers-2019/ 2019-06-27T16:27:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/polycystic-ovary-syndrome-treatment/ 2019-06-27T15:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/uk-digital-health-2019/ 2019-06-27T14:22:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/osteoporosis-prevention-2019/ 2023-01-04T11:10:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/success-of-hpv-vaccination-high-income-countries/ 2019-06-27T10:37:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ai-drug-failures/ 2019-06-27T10:49:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/almirall-eib-grant-skin-health/ 2023-01-19T07:42:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clinigen-marketing-authorisations-melatonin/ 2019-06-27T10:10:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-regenerons-dupixent-nasal-polyposis/ 2019-06-27T12:55:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/transforming-preparation-processes-with-the-ez-biopac-transfer-bag/ 2019-11-21T10:18:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/abbvie-allergan-merger-outlook-2019/ 2019-06-26T11:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uspto-reverses-decision-interfering-crispr-patents/ 2019-06-26T10:31:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/worlds-first-post-partum-depression-drug/ 2019-06-27T13:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/terns-genfits-elafibranor-nash/ 2023-05-29T05:33:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxb-santen-gene-therapy-retinal/ 2019-06-26T14:43:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-botox-maker-allergan-acquisition/ 2019-06-26T13:50:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biggest-pharmaceutical-lawsuits/ 2024-05-08T10:54:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/psoriatic-arthritis-treatment-2019/ 2019-06-25T15:26:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/zynteglo-gene-therapy-2019/ 2022-03-24T10:22:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-opdivo-fails-to-reach-primary-endpoint-in-hcc/ 2019-06-25T09:24:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/nash-drugs-in-development-the-race-to-market/ 2020-02-12T11:47:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/molnlycke-zuellig-wound-care/ 2023-06-01T10:48:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/human-sperm-outer-space/ 2019-06-25T15:09:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-otezla-merger-celgene/ 2019-06-25T10:09:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/veeva-rd-summit-clinical-trials-of-the-future/ 2023-01-24T16:51:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-symdeko-cf-label-expansion/ 2019-06-24T13:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gene-therapy-for-neurological-disorders/ 2023-06-08T04:43:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/most-expensive-drugs-us/ 2022-03-23T10:31:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/seaweed-and-cancer-antibiotics/ 2023-05-26T04:50:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shionogi-license-out-lusutrombopag/ 2019-06-24T12:53:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-botox-upper-limb-spasticity/ 2019-06-24T13:46:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-approval-inhibitor-talzenna/ 2019-06-24T10:26:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/climate-change-big-pharma-2019/ 2019-06-21T13:09:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-may-2019 2019-06-21T12:00:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/venture-capital/pharma-industry-venture-financing-deals-in-may-2019 2019-06-21T11:59:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-iluvien-nipu/ 2019-06-21T11:14:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/mnd-genetic-mutations-drug-development/ 2019-06-21T08:47:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/piramal-hpapi-riverview-facility/ 2019-06-21T12:33:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-paediatric-medicines-manufacturing/ 2019-06-20T13:45:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-sale-consumer-health/ 2019-06-25T05:17:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-the-deep-dive-for-new-drugs/ 2019-06-20T15:36:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/europe-pharma-industry-deals-in-may-2019 2019-06-20T13:48:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-ma-deals-in-may-2019 2019-06-20T13:31:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-deals-in-may-2019 2019-06-20T13:14:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/protein-degradation-drugs-gilead-nurix/ 2019-06-20T10:07:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/north-america-pharma-industry-deals-in-may-2019 2019-06-20T09:06:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-university-of-washington/ 2019-06-20T09:55:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ricoh-elixirgen-drug-discoveries/ 2019-06-20T10:15:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-keytruda-fda-sclc/ 2019-06-21T09:15:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/idiopathic-pulmonary-fibrosis-treatment-2019/ 2021-12-01T12:15:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/advantages-of-digital-printing-technology-in-blister-packaging/ 2019-11-21T10:15:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hidradenitis-suppurativa-treatment-2019/ 2019-06-19T12:39:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/norovirus-vaccine-progress-antibody/ 2019-06-19T11:05:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-deals-in-may-2019 2019-06-19T06:35:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lynparza-eu-japan/ 2019-06-19T11:06:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-roches-tumour-rozlytrek/ 2019-06-20T06:23:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/canada-makes-history-in-basketball-and-pharmacare-html/ 2021-11-02T03:16:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisks-diabetes-victoza/ 2019-06-19T10:12:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/axial-spondyloarthritis-treatment/ 2022-11-30T14:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/exhausted-t-cells-identification-infection/ 2019-06-19T14:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mycovia-hengrui-medicine-vt-1161-rvvc/ 2023-05-15T03:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-acquire-array-biopharma/ 2019-06-18T10:16:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-google-healthcare-innovation-lab/ 2019-06-18T09:43:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mitochondrial-disease-treatment-2019/ 2019-06-17T16:29:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vascepa-versus-epanova/ 2022-12-01T16:55:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-tremfya-psoriatic-arthritis/ 2019-06-17T13:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/diabetes-drug-development-2019/ 2022-03-15T06:59:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mhnpc-treatment-2019/ 2019-06-17T10:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/theravance-mylan-nebulised-revefenacin/ 2021-11-25T10:48:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/upsher-smith-buys-reddys-migraine-drugs/ 2019-06-17T11:01:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-allergan-fda-herceptin-kanjinti/ 2019-06-17T09:09:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/inconsistent-application-pricing-policies-china-html/ 2021-11-02T03:16:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-blockchain-pilot/ 2019-12-23T10:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/egis-pharma-mundipharma-pelmeg-deal/ 2022-11-23T11:26:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-california-uni-crispr-research/ 2019-06-14T10:28:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synlogic-ginkgo-bioworks-alliance/ 2019-06-14T09:58:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/prostate-cancer-trials-2019/ 2019-06-13T15:20:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/preventative-migraine-treatment/ 2022-02-15T07:23:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/esketamine-benefits/ 2019-06-13T11:01:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dassault-medidata-acquisition/ 2019-06-13T10:45:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/china-pharmaceutical-industry-2019/ 2021-11-22T09:31:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmab-janssen-cd38-antibody-deal/ 2019-06-13T09:36:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-keytruda-expanded-indications-us/ 2019-06-13T09:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-acquires-emapalumab/ 2019-06-13T14:47:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/stroke-prevalent-cases-to-2027/ 2023-01-19T06:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/breast-cancer-and-cpis/ 2019-06-12T12:42:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deciphera-zai-lab-ripretinib-licensing/ 2021-11-25T10:24:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-dundee-uni-protac-drugs/ 2019-06-12T09:56:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/exscientia-gt-apeiron-alliance/ 2019-12-23T10:53:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/progeria-treatment-advances/ 2019-06-12T12:14:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/microbiome-in-ibd/ 2019-06-11T15:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/metastatic-breast-cancer-2019/ 2019-06-11T14:38:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/preterm-births-2015/ 2023-01-04T11:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-opdivo-plus-yervoy-nhs-scotland/ 2019-06-11T10:02:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-acquires-tilos-therapeutics/ 2019-06-11T09:49:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-spark-therapeutics-ftc-request/ 2019-06-11T09:25:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-polivy-fda-approval/ 2019-06-11T09:35:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/metastatic-breast-cancer-treatment/ 2021-11-25T11:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/amyloidosis-treatment-2019/ 2023-01-04T11:29:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/diabetes-week-future-treatment-type-1-diabetes/ 2020-01-31T13:54:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nefecon-greater-china-singapore/ 2019-06-10T14:03:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rls-treatment-2019/ 2019-06-10T13:24:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/medicinal-cannabis-2019/ 2019-06-10T10:30:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pancreatic-cancer-treatment-2019/ 2019-06-10T09:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/medidata-moving-towards-virtualised-patient-centric-trials/ 2023-01-24T16:52:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-panel-tb-alliance-pretomanid/ 2019-06-10T09:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-nightstar-therapeutics-acquisition/ 2019-06-10T11:09:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-nference-ai-drug-development/ 2019-12-23T10:53:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/haemophilia-b-treatment/ 2019-06-07T16:22:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-myeloma-treatment-2019/ 2019-06-07T13:00:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/epilepsy-treatment-2019/ 2023-05-31T04:51:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/calquence-superiority-chemotherapy-cll/ 2019-06-07T10:45:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/columbia-university-deerfield-alliance/ 2019-06-07T09:16:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-buys-exonics-therapeutics/ 2019-06-07T12:23:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sierra-oncology-fast-track-momelotinib/ 2019-06-07T08:49:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/big-pharma-pollution-2019/ 2019-06-06T14:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-new-drug-target-tuberculosis/ 2023-02-09T05:03:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/non-small-cell-lung-cancer-2019/ 2019-06-06T13:27:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/non-small-cell-lung-cancer/ 2019-06-06T12:35:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/abbvie-shoots-for-aan-2020-target-readout-for-phase-ii-ms-trials-at-current-enrolment-rate/ 2023-01-24T16:52:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novartis-ms-drug-delays-denied/ 2019-06-06T09:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-acceleron-luspatercept-bla/ 2019-06-06T09:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insys-225m-us-marketing-probe/ 2019-06-06T13:19:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-arvinas-partnership/ 2021-11-23T07:15:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-emgality-cluster-headaches-approval/ 2019-06-05T14:36:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ovarian-cancer-treatment/ 2023-02-03T10:46:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nme-approvals-2018/ 2022-03-11T07:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-project-facilitate-unapproved-drugs/ 2019-06-05T09:05:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nucala-self-administration-chmp-opinion/ 2019-06-05T10:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ema-orphan-designations/ 2019-06-04T16:31:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ipf-treatment-2019/ 2021-12-01T12:30:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/treatment-of-uterine-fibroids/ 2019-06-04T13:40:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/safer-car-t-therapy/ 2019-06-04T12:25:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/her2-breast-cancer-trials/ 2023-03-15T08:57:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pembrolizumab-chemotherapy-recurrent-head-and-neck-cancer/ 2019-06-04T10:58:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/who-and-drug-pricing/ 2019-06-04T08:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-atomwise-ai-drug-discovery/ 2019-12-23T10:53:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-fda-approval-zerbaxa/ 2022-12-03T08:47:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-conditional-approval-zynteglo/ 2019-06-04T10:40:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/berkeley-chinese-crispr-babies-risk-of-early-death/ 2019-12-23T10:50:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lynparza-brca-pancreatic-cancer-mutation/ 2019-06-03T13:31:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/why-drug-prices-are-so-high/ 2019-06-03T13:07:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aslan-pharmaceuticals-rights-csl-asset/ 2019-06-03T12:31:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-review-beigene-tislelizumab/ 2019-06-03T12:31:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beam-therapeutics-bio-palette-deal/ 2019-06-03T11:09:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pain-pipeline-2019/ 2019-05-31T16:05:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/maternal-vaccine-outlook-2019/ 2019-05-31T15:28:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cmo-outsourcing-2018/ 2019-05-31T14:19:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-combination-asthma-drug-phase-iii/ 2019-05-31T10:39:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/may-2019-top-news-stories-pharma/ 2019-06-11T08:52:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amarin-vascepa-fda-priority-review-cv-indication/ 2019-05-31T09:47:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iovance-biotherapeutics-new-plant/ 2019-05-31T09:24:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-gubra-obesity-alliance/ 2019-05-31T10:28:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biologic-drugs-2019/ 2023-05-12T11:48:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gene-therapy-manufacturing-2019/ 2019-05-30T11:55:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/triple-combination-multiple-myeloma-janssen/ 2019-05-30T10:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/prostate-diagnosis-at-stage-iv/ 2019-05-30T08:46:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/trend-in-antimicrobial-resistance-sewage-bad-sanitation/ 2019-05-30T08:36:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drug-pricing-transparency-resolution/ 2019-05-30T09:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approva-vraylar-bipolar-depression/ 2019-05-30T09:32:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/argentina-announces-innovative-reimbursement-deal-for-spinraza-html/ 2021-11-02T03:17:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amicus-therapeutics-penn-expand-deal/ 2023-04-06T10:11:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-ms-day-ocrevus-breakthrough-ms-treatment/ 2019-05-30T07:57:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/spinal-muscular-atrophy-therapies/ 2019-05-29T14:53:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-celgene-revlimid-combination-indolent-lymphoma/ 2019-05-29T14:22:16+00:00 daily 1.0 https://www.pharmaceutical-technology.com/analyst-comment/crohns-disease-study/ 2019-05-29T14:05:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/universal-flu-vaccine-2019/ 2023-03-12T16:57:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acne-clinical-trials-2019/ 2023-01-24T16:53:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/could-a-pregnancy-protein-hold-promise-for-new-drugs/ 2019-05-28T08:58:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/british-columbia-biologics-biosimilars-switch/ 2019-05-29T09:37:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-compound-kills-superbugs/ 2019-05-29T09:20:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-licences-centrexion-pain-asset/ 2019-05-29T08:38:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/prostate-cancer-treatment-2019/ 2019-05-28T15:07:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/atopic-dermatitis-treatment-2020/ 2023-06-26T05:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-novartis-piqray-pik3ca-mutation/ 2019-05-28T13:16:12+00:00 daily 1.0 https://www.pharmaceutical-technology.com/features/scott-gottlieb-achievements-outgoing-fda-commissioner/ 2019-05-28T08:34:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/most-read/length-of-clinical-trials/ 2023-01-24T16:53:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-oklahoma-opioid-case-settlement/ 2019-05-28T12:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-avexis-zolgensma-fda-nod/ 2019-05-28T14:56:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-discovery-global-strepa-vaccine/ 2019-05-28T14:23:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-deals-in-april-2019 2019-05-27T08:12:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/venture-capital/us-pharma-industry-venture-financing-deals-in-april-2019 2019-05-27T07:43:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/north-america-pharma-industry-deals-in-april-2019 2019-05-24T16:44:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-deals-in-april-2019 2019-05-24T16:20:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-digitising-the-api-supply-chain/ 2019-05-24T13:29:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/colorado-insulin-price-cap/ 2019-05-24T11:31:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prochlorperazine-anti-competitive-practices-uk/ 2019-05-24T08:28:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-approves-gsk-shingrix/ 2019-05-29T07:58:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-half-price-humalog-insulin/ 2019-05-24T10:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-life-sciences-pop-up/ 2020-03-26T13:07:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-trade-tech-pop-up/ 2020-03-26T13:03:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-trade-create-pop-up/ 2020-03-26T13:07:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-vaccine-manufacturing/ 2019-05-23T14:46:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/celgenes-pomalyst/ 2023-01-09T04:09:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/china-in-licensing-deals/ 2021-10-27T12:54:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chugai-pharmaceutical-new-research-lab/ 2021-10-31T14:59:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-invokana-fda-priority-review/ 2019-05-23T09:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-nuevolution-acquisition-offer/ 2019-05-23T09:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/ilc-dovers-new-cork-manufacturing-plant-includes-10500-sq-ft-of-clean-room-capability/ 2020-01-16T10:03:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pneumococcal-vaccine-2019/ 2019-05-22T14:42:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-opioid-less-side-effects-faster-results-tulane/ 2023-01-10T09:45:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizer-acquires-therachon-to-broaden-its-rare-disease-pipeline/ 2019-05-22T13:32:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hepatitis-a-incidence-rate/ 2019-05-22T11:36:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/challenges-with-dementia-treating-multifaceted-condition/ 2021-12-03T10:06:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-hhs-cms-lawsuit/ 2019-05-22T10:39:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-acquires-just-biotherapeutics/ 2019-05-22T09:25:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-buys-peloton-therapeutics/ 2019-05-22T11:30:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/spravato-cost/ 2019-05-21T15:07:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alzheimers-drug-t3d-funding-nih/ 2019-05-21T11:10:59+00:00 daily 2.0 https://www.pharmaceutical-technology.com/features/top-selling-prescription-drugs/ 2024-05-10T07:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-april-2019 2019-05-21T04:05:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/catalent-acquires-paragon-bioservices/ 2019-05-21T10:38:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/flexipharm-austrading-therapy-launch/ 2019-05-21T09:42:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/schrodinger-fund-raising/ 2019-12-23T10:53:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/haemophilia-a-treatment/ 2023-04-06T09:45:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/car-t-cell-therapy-cost/ 2019-05-20T14:18:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lifearc-rights-to-keytruda-1bn-ccpid/ 2019-05-20T11:49:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/venture-capital/pharma-industry-venture-financing-deals-in-april-2019 2019-05-20T10:04:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-ma-deals-in-april-2019 2019-05-20T09:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/healthcare-ma-advisers-q1-2019/ 2019-05-20T12:22:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-fda-nod-venclexta-gazyva-cll/ 2019-05-20T15:06:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/australia-court-gsk-novartis/ 2019-05-20T10:27:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/parvus-therapeutics-genentech-alliance/ 2019-05-20T10:13:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ibd-treatment/ 2019-05-17T14:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/psoriasis-treatment-2019/ 2019-05-17T08:45:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-frazier-phathom-pharmaceuticals/ 2023-04-04T08:59:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-zymeworks-deal-expansion/ 2021-11-25T09:43:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-fragmin-paediatric-fda-approval/ 2019-05-17T10:07:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/new-paymentbyresults-and-payback-regulations-for-bulgaria-html/ 2021-11-02T03:18:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trump-and-drug-pricing/ 2019-05-16T16:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/2018-global-prescription-drug-sales-fall-against-q4-forecasts/ 2019-05-16T11:31:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-cancer-resistance-programme/ 2019-05-16T15:44:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-spinraza-nhs-funding/ 2019-05-16T10:22:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-kymera-alliance/ 2019-05-16T08:14:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alzheimer-s-disease-late/ 2019-05-15T14:06:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/diabetic-macular-edema-drug/ 2023-01-23T12:54:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rheumatoid-arthritis-prevalence/ 2022-11-29T15:39:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-pomalyst-breakthrough-status/ 2023-01-09T04:09:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-boehringer-biosimilar-settlement/ 2019-05-15T09:40:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-advisory-panel-quizartinib-vote/ 2019-05-15T12:40:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bacteriophage-therapy/ 2023-02-09T05:03:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/real-world-evidence-in-pharma/ 2019-05-14T11:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zealand-phase-iii-results-hypoglycaemia/ 2023-09-12T04:06:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/psoriasis-and-mental-health-mental-health-awareness-week/ 2019-05-14T08:46:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-brain-cancer-treatment-aid/ 2019-05-14T13:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elevatebio-gene-therapy-companies/ 2019-05-14T10:28:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-cyramza-fda-approval-liver-cancer/ 2019-05-14T10:32:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cbd-outlook-2019/ 2019-05-13T15:33:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/crohns-disease-drug/ 2022-03-24T12:24:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ulcerative-colitis-incidence/ 2019-05-13T11:33:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/industry-review-on-uk-drug-discovery-emphasises-future-of-ai-and-ccms/ 2019-05-13T11:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/type-1-diabetes-treatment/ 2023-05-08T05:29:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-myeloma-2027/ 2023-08-29T04:10:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pruritus-treatment/ 2023-06-26T05:45:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-new-biological-therapies-facility/ 2019-05-13T09:53:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-29-drugmakers-price-fixing-lawsuit/ 2019-05-13T10:28:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sunovion-breakthrough-schizophrenia-drug/ 2019-05-13T10:00:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/takeda-divestments/ 2019-05-10T15:53:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/c-difficile-treatment/ 2022-11-29T14:35:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-opdivo-glioblastoma-failure/ 2019-05-10T13:28:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/uk-healthcare-industry-analysis-2019/ 2019-12-23T10:50:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/her2-metastatic-breast-cancer-treatment/ 2022-02-08T13:20:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/remyelination-ms-trial/ 2023-01-24T16:53:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-ocrevus-nhs-england/ 2019-05-10T14:27:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-goldfinch-bio-deal/ 2019-05-13T05:57:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akcea-ionis-waylivra-ec-authorisation/ 2019-05-10T10:24:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mcrpc-treatment/ 2019-05-09T16:37:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/plaque-psoriasis/ 2023-05-10T04:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/urinary-tract-infection-antibiotics/ 2019-05-09T14:30:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ketamine-based-pipeline-drugs/ 2019-05-09T08:32:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-purchases-therachon/ 2019-05-09T14:24:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-novartis-xiidra-deal/ 2019-05-09T09:39:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-dupixent-ec-approval-asthma/ 2019-05-09T10:03:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/meniere-disease-and-ebselen/ 2019-05-08T15:12:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ptsd-and-comorbidity/ 2023-05-10T04:31:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/skin-cancer-prevention-treatments-drug-resistance/ 2023-02-03T08:55:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/migraine-prevention-drug/ 2019-05-08T11:15:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hypercholesterolemia-treatment/ 2019-05-08T10:47:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/congo-wide-ebola-vaccination/ 2019-05-08T15:34:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/verve-therapeutics-launch-fundraising/ 2019-05-08T11:06:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-ruzurgi-paediatric-lems/ 2019-05-08T10:35:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bladder-cancer-treatment/ 2019-05-07T11:10:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bicycle-ddf-drug-development-cns-conditions/ 2019-05-07T10:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rheumatoid-arthritis-biosimilars/ 2022-11-29T15:40:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lundbeck-acquires-abide-therapeutics/ 2019-05-07T09:30:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/skyhawk-takeda-partnership/ 2019-05-07T09:43:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-pfizer-vyndaqel/ 2019-05-07T09:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-asthma-day-new-asthma-drugs-2019/ 2020-01-31T13:42:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/april-2019-top-news-stories-pharma/ 2019-05-09T07:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/renal-cell-carcinoma-treatment/ 2022-11-25T16:55:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/art-prevents-hiv-transmission-gay-men/ 2019-05-03T11:04:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hikma-100th-injectable-medicine/ 2019-05-03T10:00:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-syapse-precision-medicine-deal/ 2019-05-03T13:54:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-transgene-partnership/ 2019-05-03T10:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/zolgensma-may-be-a-potential-gamechanger-for-sma-html/ 2021-11-02T03:18:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/italy-pharma-industry/ 2019-05-02T16:13:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nanoparticle-drug-conjugate/ 2021-10-27T12:35:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genkyotex-pbc-drug-efficacy-data/ 2022-11-24T12:15:54+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/sanofi-dengvaxia-gets-fda-approval/ 2019-05-03T04:42:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-global-drug-research-facility-us/ 2019-05-02T11:30:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-measles-vaccine-production/ 2019-05-02T13:43:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eli-lilly-performance-2019/ 2019-05-01T15:47:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ovarian-cancer-trials/ 2023-02-03T10:45:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-expands-label-of-first-universal-hepatitis-c-drug/ 2019-05-01T13:10:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/top-10-drugs-in-biosimilar-trials/ 2023-06-06T07:09:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/celgene-dlbcl-clinical-trials/ 2022-07-11T08:54:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/history-of-the-ema-as-it-leaves-london/ 2019-04-26T10:53:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-eirgenix-deal/ 2019-05-01T13:01:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-acquires-lemborexant-rights/ 2019-05-01T09:50:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-benevolentai-alliance/ 2019-12-23T10:53:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/polyprox-oncology-drugs-seed-financing/ 2019-04-30T17:02:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/anti-ageing-drug-research/ 2019-04-30T10:00:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/venture-capital/pharma-industry-venture-financing-deals-in-q1-2019 2019-04-30T04:43:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/un-antimicrobial-resistance-report/ 2019-04-30T13:07:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-pharma-majors-fight-hepatitis-c/ 2019-05-01T05:42:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-iktos-ai-technology-drug/ 2019-12-23T10:54:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ibm-watson-ai-healthcare/ 2022-11-23T12:17:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/neurology-pipeline-2019/ 2022-03-23T16:51:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-immunization-week-non-communicable-diseases/ 2019-05-07T08:11:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/x-scid-treatment/ 2022-03-24T10:37:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/victoza-children-and-adolescents-with-type-2-diabetes/ 2019-04-29T10:03:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/top-orphan-drugs-oncology/ 2023-05-30T03:30:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/runlabs-empowering-life-science-through-flexible-working-environments/ 2022-02-14T10:50:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-benlysta-systemic-lupus-erythematosus/ 2019-04-29T13:51:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-msd-lynparza/ 2019-04-29T10:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/praluent-fda-nod-cardiac-indications/ 2019-04-29T10:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/chemical-api-manufacturing-2019/ 2021-10-25T09:51:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/small-molecule-manufacturing/ 2022-03-11T07:57:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/viral-vector-manufacturing-2019/ 2022-07-18T06:10:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eccmid-2019-improving-european-vaccination-policy/ 2019-04-26T10:18:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ipf-incidence-uk/ 2019-04-26T09:53:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/regeneron-alnylam-sanofi-rnai-partnerships-what-does-the-future-hold/ 2019-04-26T09:39:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/non-hormonal-contraception-amphora/ 2019-04-26T09:02:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/anxiety-orders-prevalence-major-markets/ 2023-08-09T04:14:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-deals-in-march-2019 2019-04-26T05:27:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/news/pharma-industry-venture-financing-deals-in-march-2019 2019-04-26T05:25:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-deals-in-q1-2019 2019-06-06T11:56:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-vaccine-manufacturing-boost/ 2019-04-26T09:28:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-withdraws-cancer-drug-lartruvo/ 2023-01-11T17:16:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-astellas-copay-kickback-charges/ 2019-04-26T10:16:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-is-a-memory-loss-drug-on-the-horizon/ 2020-01-24T11:00:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/4-3m-donated-to-paths-visualise-no-malaria-scheme/ 2019-12-23T10:55:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/europe-pharma-industry-deals-in-march-2019 2019-04-25T13:41:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zipline-ghana-medical-supplies-drones/ 2019-12-23T10:55:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/spinal-muscular-atrophy-research-challenges/ 2023-01-19T06:38:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-march-2019 2019-04-25T04:56:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-breakthrough-la-jolla-malaria-drug/ 2019-04-25T14:35:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fsd-pharma-buys-prismic-pharmaceuticals/ 2019-04-25T08:29:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/forge-therapeutics-basilea-alliance/ 2019-05-01T08:46:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/antivenom-supply-snake-bites/ 2020-01-31T13:50:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adagene-adc-therapeutics-oncology-antibody/ 2019-12-23T10:50:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/antibiotics-2019/ 2019-04-25T16:57:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-discontinues-trial-of-ajovy-for-episodic-cluster-headache/ 2022-07-11T08:54:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/the-us-pharma-industry-deals-in-march-2019 2019-04-24T04:21:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/north-america-pharma-industry-deals-in-march-2019 2019-04-24T04:17:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-generic-vesicare-us-launch/ 2022-11-14T13:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-skyrizi-fda-nod-plaque-psoriasis/ 2022-03-29T11:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fulcrum-buys-gsk-losmapimod-rights/ 2019-04-24T09:13:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/connect-everything-in-your-business/ 2019-08-01T09:52:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/worlds-first-malaria-vaccine-malawi/ 2019-04-24T11:00:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/crreo-pouches/ 2019-04-24T08:12:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-taltz-phase-iii-study-nr-axspa/ 2019-04-23T14:17:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/parkinsons-disease-treatment-2019/ 2019-04-23T12:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/comprehensive-heating-solution/ 2019-05-01T10:49:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-closes-clementia-pharmaceuticals-buy/ 2021-10-29T08:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-avidity-biosciences-alliance/ 2019-04-23T11:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/keytruda-kidney-cancer-indication-fda-approval/ 2019-04-23T15:39:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/pharma-industry-ma-deals-in-q1-2019 2019-06-06T11:56:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/parkinsons-disease-trial/ 2022-07-11T08:54:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/schizophrenia-treatment-roluperidone/ 2019-04-19T11:08:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/venture-capital/us-pharma-industry-venture-financing-deals-in-q1-2019 2019-06-06T11:57:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/future-of-viiv-s-dovato/ 2019-04-18T14:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisk-oral-glp-1/ 2019-04-18T14:21:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alexa-skills-pharma/ 2019-04-18T14:00:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-breakthrough-genfit-elafibranor/ 2023-06-26T05:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-puretech-alliance/ 2019-04-18T11:22:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crispr-helps-treat-lung-disease/ 2019-04-18T09:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-nice-recommends-akcea-tegsedi/ 2019-04-17T16:23:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pulmatrix-cipla-pulmazole-deal/ 2022-07-29T11:02:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-insitro-nash-drug-discovery/ 2019-04-17T11:16:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/india-issues-new-clinical-trial-rules-expedite-new-drug-html/ 2021-11-02T03:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/action-medical-research-timeline/ 2019-04-16T16:30:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-strategy-shows-promise-in-hunt-for-universal-influenza-vaccine/ 2019-04-17T15:07:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rheumatoid-arthritis-drug-filgotinib/ 2022-11-29T15:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/catalent-buys-paragon-bioservices/ 2019-04-17T05:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enesi-pharma-barda-new-flu-vaccines/ 2019-04-16T11:18:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dnanexus-sutter-health-upmc-ms-study/ 2019-04-16T15:59:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/us-pharma-industry-ma-deals-in-q1-2019 2019-06-06T11:58:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-celgene-acquisition/ 2019-04-15T15:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agroceutical-products-daffodils-alzheimers/ 2019-04-15T09:25:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-balversa-fda-nod/ 2019-04-15T09:33:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/stroke-and-alcohol-consumption/ 2019-04-12T13:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-insulin-cost-cut-us/ 2019-04-12T09:18:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/askbio-secures-investment/ 2019-04-12T15:50:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-commercialises-shionogi-rizmoic/ 2019-04-12T11:08:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/open-science-drug-development/ 2019-04-12T09:01:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-myeloma-incidence/ 2023-07-31T03:09:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/future-of-crispr-transform-genome-therapy/ 2019-04-09T14:36:40+00:00 daily 0.2